| 000 | 00926 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513123415.0 | ||
| 264 | 0 | _c19970828 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.315.7101.187a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBevan, E | |
| 245 | 0 | 0 |
_aTuberculosis treatment is expensive for patients in developing countries. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cJul 1997 |
||
| 300 |
_a187-8 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xeconomics |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 315 _gno. 7101 _gp. 187-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.315.7101.187a _zAvailable from publisher's website |
| 999 |
_c9231278 _d9231278 |
||